- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this study, over the next five years the Biopharmaceutical CMO & CRO market will register a 7.9%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ 2457.4 million in 2019. In particular, this report presents the global revenue market share of key companies in Biopharmaceutical CMO & CRO business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical CMO & CRO market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Biopharmaceutical CMO & CRO, covering the supply chain analysis, impact assessment to the Biopharmaceutical CMO & CRO market size growth rate in several scenarios, and the measures to be undertaken by Biopharmaceutical CMO & CRO companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Biologics
Biosimilars
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Contract Manufacturing
Contract Research
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Lonza
Samsung BioLogics
Boehringer Ingelheim GmbH
Inno Biologics Sdn Bhd
JRS Pharma (Celonic GmbH)
Rentschler Biotechnologie GmbH
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
BIOMEVA GmbH
TOYOBO CO., LTD
ProBioGen
Patheon
AbbVie Inc.
Binex Co., Ltd.
WuXi Biologics.
CMC Biologics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biopharmaceutical CMO & CRO market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Biopharmaceutical CMO & CRO market by identifying its various subsegments.
Focuses on the key global Biopharmaceutical CMO & CRO players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biopharmaceutical CMO & CRO with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Biopharmaceutical CMO & CRO submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CMO & CRO Market Size 2015-2025
2.1.2 Biopharmaceutical CMO & CRO Market Size CAGR by Region
2.2 Biopharmaceutical CMO & CRO Segment by Type
2.2.1 Biologics
2.2.2 Biologics
2.3 Biopharmaceutical CMO & CRO Market Size by Type
2.3.1 Global Biopharmaceutical CMO & CRO Market Size Market Share by Type (2015-2020)
2.3.2 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type (2015-2020)
2.4 Biopharmaceutical CMO & CRO Segment by Application
2.4.1 Contract Manufacturing
2.4.2 Contract Research
2.5 Biopharmaceutical CMO & CRO Market Size by Application
2.5.1 Global Biopharmaceutical CMO & CRO Market Size Market Share by Application (2015-2020)
2.5.2 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Application (2015-2020)
3 Global Biopharmaceutical CMO & CRO by Players
3.1 Global Biopharmaceutical CMO & CRO Market Size Market Share by Players
3.1.1 Global Biopharmaceutical CMO & CRO Market Size by Players (2018-2020)
3.1.2 Global Biopharmaceutical CMO & CRO Market Size Market Share by Players (2018-2020)
3.2 Global Biopharmaceutical CMO & CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biopharmaceutical CMO & CRO by Regions
4.1 Biopharmaceutical CMO & CRO Market Size by Regions
4.2 Americas Biopharmaceutical CMO & CRO Market Size Growth
4.3 APAC Biopharmaceutical CMO & CRO Market Size Growth
4.4 Europe Biopharmaceutical CMO & CRO Market Size Growth
4.5 Middle East & Africa Biopharmaceutical CMO & CRO Market Size Growth
5 Americas
5.1 Americas Biopharmaceutical CMO & CRO Market Size by Countries
5.2 Americas Biopharmaceutical CMO & CRO Market Size by Type
5.3 Americas Biopharmaceutical CMO & CRO Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Biopharmaceutical CMO & CRO Market Size by Regions
6.2 APAC Biopharmaceutical CMO & CRO Market Size by Type
6.3 APAC Biopharmaceutical CMO & CRO Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Biopharmaceutical CMO & CRO by Countries
7.2 Europe Biopharmaceutical CMO & CRO Market Size by Type
7.3 Europe Biopharmaceutical CMO & CRO Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Biopharmaceutical CMO & CRO by Countries
8.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type
8.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Biopharmaceutical CMO & CRO Market Forecast
10.1 Global Biopharmaceutical CMO & CRO Market Size Forecast (2021-2025)
10.2 Global Biopharmaceutical CMO & CRO Forecast by Regions
10.2.1 Global Biopharmaceutical CMO & CRO Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Biopharmaceutical CMO & CRO Forecast by Type
10.8 Global Biopharmaceutical CMO & CRO Forecast by Application
11 Key Players Analysis
11.1 Lonza
11.1.1 Company Details
11.1.2 Biopharmaceutical CMO & CRO Product Offered
11.1.3 Lonza Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Lonza News
11.2 Samsung BioLogics
11.2.1 Company Details
11.2.2 Biopharmaceutical CMO & CRO Product Offered
11.2.3 Samsung BioLogics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Samsung BioLogics News
11.3 Boehringer Ingelheim GmbH
11.3.1 Company Details
11.3.2 Biopharmaceutical CMO & CRO Product Offered
11.3.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Boehringer Ingelheim GmbH News
11.4 Inno Biologics Sdn Bhd
11.4.1 Company Details
11.4.2 Biopharmaceutical CMO & CRO Product Offered
11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Inno Biologics Sdn Bhd News
11.5 JRS Pharma (Celonic GmbH)
11.5.1 Company Details
11.5.2 Biopharmaceutical CMO & CRO Product Offered
11.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 JRS Pharma (Celonic GmbH) News
11.6 Rentschler Biotechnologie GmbH
11.6.1 Company Details
11.6.2 Biopharmaceutical CMO & CRO Product Offered
11.6.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Rentschler Biotechnologie GmbH News
11.7 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.7.1 Company Details
11.7.2 Biopharmaceutical CMO & CRO Product Offered
11.7.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. News
11.8 BIOMEVA GmbH
11.8.1 Company Details
11.8.2 Biopharmaceutical CMO & CRO Product Offered
11.8.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 BIOMEVA GmbH News
11.9 TOYOBO CO., LTD
11.9.1 Company Details
11.9.2 Biopharmaceutical CMO & CRO Product Offered
11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 TOYOBO CO., LTD News
11.10 ProBioGen
11.10.1 Company Details
11.10.2 Biopharmaceutical CMO & CRO Product Offered
11.10.3 ProBioGen Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 ProBioGen News
11.11 Patheon
11.12 AbbVie Inc.
11.13 Binex Co., Ltd.
11.14 WuXi Biologics.
11.15 CMC Biologics
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Biopharmaceutical CMO & CRO Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Biologics
Table 5. Major Players of Biosimilars
Table 6. Biopharmaceutical CMO & CRO Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Biopharmaceutical CMO & CRO Market Size Market Share by Type (2015-2020)
Table 8. Global Biopharmaceutical CMO & CRO Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Biopharmaceutical CMO & CRO Market Size Market Share by Application (2015-2020)
Table 10. Global Biopharmaceutical CMO & CRO Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2018-2020)
Table 12. Global Biopharmaceutical CMO & CRO Key Players Head office and Products Offered
Table 13. Biopharmaceutical CMO & CRO Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biopharmaceutical CMO & CRO Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Biopharmaceutical CMO & CRO Market Size Market Share by Regions 2015-2020
Table 18. Americas Biopharmaceutical CMO & CRO Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Countries (2015-2020)
Table 20. Americas Biopharmaceutical CMO & CRO Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Type (2015-2020)
Table 22. Americas Biopharmaceutical CMO & CRO Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Application (2015-2020)
Table 24. APAC Biopharmaceutical CMO & CRO Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Regions (2015-2020)
Table 26. APAC Biopharmaceutical CMO & CRO Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Type (2015-2020)
Table 28. APAC Biopharmaceutical CMO & CRO Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Application (2015-2020)
Table 30. Europe Biopharmaceutical CMO & CRO Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Countries (2015-2020)
Table 32. Europe Biopharmaceutical CMO & CRO Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type (2015-2020)
Table 34. Europe Biopharmaceutical CMO & CRO Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Biopharmaceutical CMO & CRO
Table 43. Key Application and Potential Industries of Biopharmaceutical CMO & CRO
Table 44. Key Challenges of Biopharmaceutical CMO & CRO
Table 45. Key Trends of Biopharmaceutical CMO & CRO
Table 46. Global Biopharmaceutical CMO & CRO Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Regions
Table 48. Global Biopharmaceutical CMO & CRO Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Biopharmaceutical CMO & CRO Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Biopharmaceutical CMO & CRO Market Size Market Share Forecast by Application (2021-2025)
Table 52. Lonza Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 53. Lonza Biopharmaceutical CMO & CRO Product Offered
Table 54. Lonza Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 55. Lonza Main Business
Table 56. Lonza Latest Developments
Table 57. Samsung BioLogics Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 58. Samsung BioLogics Biopharmaceutical CMO & CRO Product Offered
Table 59. Samsung BioLogics Main Business
Table 60. Samsung BioLogics Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 61. Samsung BioLogics Latest Developments
Table 62. Boehringer Ingelheim GmbH Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 63. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product Offered
Table 64. Boehringer Ingelheim GmbH Main Business
Table 65. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 66. Boehringer Ingelheim GmbH Latest Developments
Table 67. Inno Biologics Sdn Bhd Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 68. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product Offered
Table 69. Inno Biologics Sdn Bhd Main Business
Table 70. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 71. Inno Biologics Sdn Bhd Latest Developments
Table 72. JRS Pharma (Celonic GmbH) Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 73. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product Offered
Table 74. JRS Pharma (Celonic GmbH) Main Business
Table 75. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 76. JRS Pharma (Celonic GmbH) Latest Developments
Table 77. Rentschler Biotechnologie GmbH Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 78. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product Offered
Table 79. Rentschler Biotechnologie GmbH Main Business
Table 80. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 81. Rentschler Biotechnologie GmbH Latest Developments
Table 82. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 83. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Product Offered
Table 84. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Main Business
Table 85. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 86. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Latest Developments
Table 87. BIOMEVA GmbH Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 88. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product Offered
Table 89. BIOMEVA GmbH Main Business
Table 90. BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 91. BIOMEVA GmbH Latest Developments
Table 92. TOYOBO CO., LTD Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 93. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product Offered
Table 94. TOYOBO CO., LTD Main Business
Table 95. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 96. TOYOBO CO., LTD Latest Developments
Table 97. ProBioGen Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 98. ProBioGen Biopharmaceutical CMO & CRO Product Offered
Table 99. ProBioGen Main Business
Table 100. ProBioGen Biopharmaceutical CMO & CRO Revenue and Gross Margin (2018-2020E)
Table 101. ProBioGen Latest Developments
Table 102. Patheon Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 103. AbbVie Inc. Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 104. Binex Co., Ltd. Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 105. WuXi Biologics. Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
Table 106. CMC Biologics Details, Company Total Revenue (in $ million), Head Office, Biopharmaceutical CMO & CRO Major Market Areas and Its Competitors
List of Figures
Figure 1. Biopharmaceutical CMO & CRO Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Biopharmaceutical CMO & CRO Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Biopharmaceutical CMO & CRO Market Size Market Share by Type (2015-2020)
Figure 5. Global Biologics Market Size Growth Rate
Figure 6. Global Biosimilars Market Size Growth Rate
Figure 7. Biopharmaceutical CMO & CRO in Contract Manufacturing
Figure 8. Global Biopharmaceutical CMO & CRO Market: Contract Manufacturing (2015-2020) ($ Millions)
Figure 9. Biopharmaceutical CMO & CRO in Contract Research
Figure 10. Global Biopharmaceutical CMO & CRO Market: Contract Research (2015-2020) ($ Millions)
Figure 11. Global Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2019
Figure 12. Global Biopharmaceutical CMO & CRO Market Size Market Share by Regions 2015-2020
Figure 13. Americas Biopharmaceutical CMO & CRO Market Size 2015-2020 ($ Millions)
Figure 14. APAC Biopharmaceutical CMO & CRO Market Size 2015-2020 ($ Millions)
Figure 15. Europe Biopharmaceutical CMO & CRO Market Size 2015-2020 ($ Millions)
Figure 16. Middle East & Africa Biopharmaceutical CMO & CRO Market Size 2015-2020 ($ Millions)
Figure 17. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Countries in 2019
Figure 18. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2019
Figure 19. Americas Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2019
Figure 20. United States Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 21. Canada Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 22. Mexico Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 23. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Regions in 2019
Figure 24. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2019
Figure 25. APAC Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2019
Figure 26. China Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 27. Japan Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 28. Korea Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 29. Southeast Asia Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 30. India Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 31. Australia Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 32. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Countries in 2019
Figure 33. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2019
Figure 34. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2019
Figure 35. Germany Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 36. France Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 37. UK Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 38. Italy Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 39. Russia Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 40. Spain Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Countries in 2019
Figure 42. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type in 2019
Figure 43. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application in 2019
Figure 44. Egypt Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 45. South Africa Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 46. Israel Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 47. Turkey Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 48. GCC Countries Biopharmaceutical CMO & CRO Market Size Growth 2015-2020 ($ Millions)
Figure 49. Global Biopharmaceutical CMO & CRO arket Size Forecast (2021-2025) ($ Millions)
Figure 50. Americas Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 51. APAC Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 52. Europe Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 53. Middle East & Africa Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 54. United States Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 55. Canada Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 56. Mexico Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 57. Brazil Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 58. China Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 59. Japan Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 60. Korea Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 61. Southeast Asia Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 62. India Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 63. Australia Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 64. Germany Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 65. France Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 66. UK Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 67. Italy Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 68. Russia Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 69. Spain Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 70. Egypt Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 71. South Africa Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 72. Israel Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 73. Turkey Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Figure 74. GCC Countries Biopharmaceutical CMO & CRO Market Size 2021-2025 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
